204 related articles for article (PubMed ID: 21987594)
1. Strategies, development, and pitfalls of therapeutic options for Alzheimer's disease.
Haas C
J Alzheimers Dis; 2012; 28(2):241-81. PubMed ID: 21987594
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological treatment for Alzheimer's disease: current approaches and future strategies.
Fan LY; Chiu MJ
Acta Neurol Taiwan; 2010 Dec; 19(4):228-45. PubMed ID: 21213151
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease: cholesterol a menace?
Mathew A; Yoshida Y; Maekawa T; Kumar DS
Brain Res Bull; 2011 Aug; 86(1-2):1-12. PubMed ID: 21741455
[TBL] [Abstract][Full Text] [Related]
4. Novel disease-modifying therapies for Alzheimer's disease.
Jiang T; Yu JT; Tan L
J Alzheimers Dis; 2012; 31(3):475-92. PubMed ID: 22669013
[TBL] [Abstract][Full Text] [Related]
5. Towards development of drugs targeting both amyloid and tau pathologies of Alzheimer's disease.
Shin J
Int J Geriatr Psychiatry; 2011 May; 26(5):546-8. PubMed ID: 21446001
[No Abstract] [Full Text] [Related]
6. Amyloid clearance as a treatment target against Alzheimer's disease.
Kurz A; Perneczky R
J Alzheimers Dis; 2011; 24 Suppl 2():61-73. PubMed ID: 21422524
[TBL] [Abstract][Full Text] [Related]
7. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease amyloid hypothesis at crossroads: where do we go from here?
Saxena U
Expert Opin Ther Targets; 2010 Dec; 14(12):1273-7. PubMed ID: 21058918
[TBL] [Abstract][Full Text] [Related]
9. Beyond amyloid: the future of therapeutics for Alzheimer's disease.
Lane RF; Shineman DW; Steele JW; Lee LB; Fillit HM
Adv Pharmacol; 2012; 64():213-71. PubMed ID: 22840749
[TBL] [Abstract][Full Text] [Related]
10. Advances in the therapy of Alzheimer's disease: targeting amyloid beta and tau and perspectives for the future.
Hampel H; Schneider LS; Giacobini E; Kivipelto M; Sindi S; Dubois B; Broich K; Nisticò R; Aisen PS; Lista S
Expert Rev Neurother; 2015 Jan; 15(1):83-105. PubMed ID: 25537424
[TBL] [Abstract][Full Text] [Related]
11. Novel insights for the treatment of Alzheimer's disease.
Kurz A; Perneczky R
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):373-9. PubMed ID: 20655969
[TBL] [Abstract][Full Text] [Related]
12. [Calcium hypothesis of Alzheimer disease].
Riazantseva MA; Mozhaeva GN; Kaznacheeva EV
Usp Fiziol Nauk; 2012; 43(4):59-72. PubMed ID: 23227722
[TBL] [Abstract][Full Text] [Related]
13. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM
J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
15. Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease.
Bossers K; Wirz KT; Meerhoff GF; Essing AH; van Dongen JW; Houba P; Kruse CG; Verhaagen J; Swaab DF
Brain; 2010 Dec; 133(Pt 12):3699-723. PubMed ID: 20889584
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of oxidant mechanisms in Alzheimer's disease.
Moreira PI; Smith MA; Zhu X; Santos MS; Oliveira CR; Perry G
Expert Rev Neurother; 2004 Nov; 4(6):995-1004. PubMed ID: 15853526
[TBL] [Abstract][Full Text] [Related]
17. The cholinergic system in aging and neuronal degeneration.
Schliebs R; Arendt T
Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease-related lesions.
Alafuzoff I
J Alzheimers Dis; 2013; 33 Suppl 1():S173-9. PubMed ID: 22695621
[TBL] [Abstract][Full Text] [Related]
19. The amyloid cascade hypothesis has misled the pharmaceutical industry.
Biochem Soc Trans; 2011 Aug; 39(4):920-3. PubMed ID: 21787324
[TBL] [Abstract][Full Text] [Related]
20. Preventive and therapeutic types of environmental enrichment counteract beta amyloid pathology by different molecular mechanisms.
Herring A; Lewejohann L; Panzer AL; Donath A; Kröll O; Sachser N; Paulus W; Keyvani K
Neurobiol Dis; 2011 Jun; 42(3):530-8. PubMed ID: 21406231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
